Jade Biosciences (JBIO) Research & Development (2020 - 2026)
Jade Biosciences posted quarterly Research & Development of $36.1 million for Q1 2026, up 80.06% year-on-year from $20.0 million in Q1 2025, and up 2303.53% on a QoQ basis from $1.5 million in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Research & Development data on file, last reported at $36.1 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 80.06% year-over-year to $36.1 million; the trailing twelve-month figure through Mar 2026 stood at $82.1 million (up 26.49% YoY), and the FY2025 full-year result was $93.1 million, up 75.08% from the prior year.
- Research & Development for Q1 2026 stood at $36.1 million, up from $1.5 million in the prior quarter.
- Across five years, Research & Development topped out at $36.1 million in Q1 2026 and bottomed at $78000.0 in Q2 2024.
- The 5-year median for Research & Development is $16.0 million (2023), against an average of $15.9 million.
- The widest annual swing landed in 2024, when Research & Development sank 99.51%; it then surged 28806.41% in 2025.
- A 5-year view of Research & Development shows it stood at $12.2 million in 2022, then soared by 45.76% to $17.8 million in 2023, then surged by 75.34% to $31.2 million in 2024, then sank by 95.2% to $1.5 million in 2025, then soared by 2303.53% to $36.1 million in 2026.
- The last three Research & Development figures came in at $36.1 million (Q1 2026), $1.5 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | 36.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 22.01 Mn |
| Jun 30, 2025 | 22.55 Mn |
| Mar 31, 2025 | 20.02 Mn |
| Dec 31, 2024 | 31.23 Mn |
| Sep 30, 2024 | 13.58 Mn |
| Jun 30, 2024 | 78,000.00 |
| Mar 31, 2024 | 20.08 Mn |
| Dec 31, 2023 | 17.81 Mn |
| Sep 30, 2023 | 16.88 Mn |
| Jun 30, 2023 | 16.03 Mn |
| Mar 31, 2023 | 13.49 Mn |
| Dec 31, 2022 | 12.22 Mn |
| Sep 30, 2022 | 10.78 Mn |
| Jun 30, 2022 | 8.36 Mn |
| Mar 31, 2022 | 7.26 Mn |
| Dec 31, 2021 | 5.05 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Jun 30, 2021 | 4.33 Mn |
| Mar 31, 2021 | 2.20 Mn |
| Dec 31, 2020 | 3.30 Mn |
| Sep 30, 2020 | 1.97 Mn |
| Jun 30, 2020 | 1.47 Mn |